Upgrade to SI Premium - Free Trial

CERo Therapeutics (CERO)

0.10 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/25/25 *Est.)

Latest Headlines

Form 424B3 CERO THERAPEUTICS HOLDIN May 29, 2026 4:17 PM - SEC Filing Form 8-K CERO THERAPEUTICS HOLDIN For: May 28 May 29, 2026 4:06 PM - SEC Filing Form 424B3 CERO THERAPEUTICS HOLDIN May 15, 2026 4:40 PM - SEC Filing Form 10-Q CERO THERAPEUTICS HOLDIN For: Mar 31 May 15, 2026 4:18 PM - SEC Filing CERo Therapeutics completes second cohort of phase 1 cancer trial May 11, 2026 8:15 AM - StreetInsider CERo Therapeutics Completes Second Ascending Dose Cohort of Phase 1 CER-1236 Trial May 11, 2026 8:15 AM - Globe NewsWire Form 424B3 CERO THERAPEUTICS HOLDIN May 1, 2026 4:12 PM - SEC Filing Form 8-K CERO THERAPEUTICS HOLDIN For: Apr 27 May 1, 2026 4:11 PM - SEC Filing Form 424B3 CERO THERAPEUTICS HOLDIN May 1, 2026 4:01 PM - SEC Filing Form 10-K/A CERO THERAPEUTICS HOLDIN For: Dec 31 April 30, 2026 4:35 PM - SEC Filing Form 4 CERO THERAPEUTICS HOLDIN For: Mar 04 Filed by: Francois Eric April 21, 2026 7:47 PM - SEC Filing Form 3 CERO THERAPEUTICS HOLDIN For: Feb 13 Filed by: Francois Eric April 21, 2026 7:46 PM - SEC Filing Form 424B3 CERO THERAPEUTICS HOLDIN April 15, 2026 4:59 PM - SEC Filing Form 10-K CERO THERAPEUTICS HOLDIN For: Dec 31 April 15, 2026 4:07 PM - SEC Filing Form 424B3 CERO THERAPEUTICS HOLDIN April 14, 2026 4:03 PM - SEC Filing Form 8-K CERO THERAPEUTICS HOLDIN For: Apr 08 April 14, 2026 4:01 PM - SEC Filing CERo Therapeutics doses sixth patient in phase 1 cancer trial April 14, 2026 8:15 AM - StreetInsider CERo Therapeutics Doses Third Patient in Cohort 2 of Phase 1 CER-1236 Trial April 14, 2026 8:15 AM - Globe NewsWire Form NT 10-K CERO THERAPEUTICS HOLDIN For: Dec 31 April 1, 2026 4:11 PM - SEC Filing Full Article List